Indicated for the management of the signs of mild, moderate or severe (modified NYHA Class IIa,IIb, IVc) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM). Use with concurrent therapy for congestive heart failure (i.e. furosemide, etc) on a case by case basis.
- Only FDA-approved veterinary inodilator (inotropie agent with vasodilatative properties), dilates both veins and arteries
- Works effectively and safely
- Well tolerated
- Easy to administer